| Megan Patterson, MD | |
|
700 S 52nd St, Rogers, AR 72758-8605 | |
| (479) 464-8887 | |
| Not Available |
| Full Name | Megan Patterson |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 10 Years |
| Location | 700 S 52nd St, Rogers, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164840112 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | E-10648 (Arkansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hedberg Allergy And Asthma Center Pa | 3476454026 | 5 |
| Hedberg Allergy And Asthma Center Pa | 3476454026 | 5 |
News Archive
Masimo, the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, announced today the full market release of its latest medical technology breakthrough—Masimo Rainbow Acoustic Monitoring— providing continuous and noninvasive respiration rate that is accurate, easy-to-use, and enhances patient tolerance.
A protein that protects some of our immune cells from the most common and virulent form of HIV works by starving the virus of the molecular building blocks that it needs to replicate, according to research published online in Nature Immunology.
Jazz Pharmaceuticals, today announced that the United States Patent and Trademark Office has issued a patent related to Xyrem oral solution titled "Microbiologically Sound and Stable Solutions of Gamma-Hydroxybutyrate Salt for the Treatment of Narcolepsy."
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces new data from Professor Isabelle Leclercq of Université Catholique de Louvain (Belgium) demonstrating the curative effects of GFT505 in an experimental model of NASH associated with metabolic disorders.
› Verified 8 days ago
| Entity Name | University Of Arkansas For Medical Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346230968 PECOS PAC ID: 4082528955 Enrollment ID: O20040115000431 |
News Archive
Masimo, the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, announced today the full market release of its latest medical technology breakthrough—Masimo Rainbow Acoustic Monitoring— providing continuous and noninvasive respiration rate that is accurate, easy-to-use, and enhances patient tolerance.
A protein that protects some of our immune cells from the most common and virulent form of HIV works by starving the virus of the molecular building blocks that it needs to replicate, according to research published online in Nature Immunology.
Jazz Pharmaceuticals, today announced that the United States Patent and Trademark Office has issued a patent related to Xyrem oral solution titled "Microbiologically Sound and Stable Solutions of Gamma-Hydroxybutyrate Salt for the Treatment of Narcolepsy."
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces new data from Professor Isabelle Leclercq of Université Catholique de Louvain (Belgium) demonstrating the curative effects of GFT505 in an experimental model of NASH associated with metabolic disorders.
› Verified 8 days ago
| Entity Name | Hedberg Allergy And Asthma Center Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295820918 PECOS PAC ID: 3476454026 Enrollment ID: O20040116000205 |
News Archive
Masimo, the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, announced today the full market release of its latest medical technology breakthrough—Masimo Rainbow Acoustic Monitoring— providing continuous and noninvasive respiration rate that is accurate, easy-to-use, and enhances patient tolerance.
A protein that protects some of our immune cells from the most common and virulent form of HIV works by starving the virus of the molecular building blocks that it needs to replicate, according to research published online in Nature Immunology.
Jazz Pharmaceuticals, today announced that the United States Patent and Trademark Office has issued a patent related to Xyrem oral solution titled "Microbiologically Sound and Stable Solutions of Gamma-Hydroxybutyrate Salt for the Treatment of Narcolepsy."
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces new data from Professor Isabelle Leclercq of Université Catholique de Louvain (Belgium) demonstrating the curative effects of GFT505 in an experimental model of NASH associated with metabolic disorders.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Megan Patterson, MD 700 S 52nd St, Rogers, AR 72758-8605 Ph: (479) 464-8887 | Megan Patterson, MD 700 S 52nd St, Rogers, AR 72758-8605 Ph: (479) 464-8887 |
News Archive
Masimo, the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, announced today the full market release of its latest medical technology breakthrough—Masimo Rainbow Acoustic Monitoring— providing continuous and noninvasive respiration rate that is accurate, easy-to-use, and enhances patient tolerance.
A protein that protects some of our immune cells from the most common and virulent form of HIV works by starving the virus of the molecular building blocks that it needs to replicate, according to research published online in Nature Immunology.
Jazz Pharmaceuticals, today announced that the United States Patent and Trademark Office has issued a patent related to Xyrem oral solution titled "Microbiologically Sound and Stable Solutions of Gamma-Hydroxybutyrate Salt for the Treatment of Narcolepsy."
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces new data from Professor Isabelle Leclercq of Université Catholique de Louvain (Belgium) demonstrating the curative effects of GFT505 in an experimental model of NASH associated with metabolic disorders.
› Verified 8 days ago
Bryan M Harvey, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 900 S 52nd St, 200, Rogers, AR 72758 Phone: 479-254-1100 Fax: 479-254-2997 | |
Dr. Martha Ann B Sharkey, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5507 Walsh Ln, Suite 101, Rogers, AR 72758 Phone: 479-464-8231 Fax: 479-464-8230 | |
Dr. Virginia Brown Neaville, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2708 Rife Medical Lane, Suite 130, Rogers, AR 72758 Phone: 479-338-5555 Fax: 479-338-5533 | |
Dr. Matthew Cort Bell, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 700 S 52nd St, Rogers, AR 72758 Phone: 479-464-8887 Fax: 479-464-9949 | |
Dr. Janet Susan Cantwell, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 900 S 52nd St, Suite 200, Rogers, AR 72758 Phone: 479-254-1100 Fax: 479-254-2997 | |
Dr. Cassie Jackson Dyer, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3101 Se 14th St, Rogers, AR 72758 Phone: 479-636-9234 |